Weight Management

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.

LOS ANGELES — In a presentation at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, speakers highlighted recent data from the TIMI Study Group on treatment options for diabetes and CVD.